"UPMC Hillman Cancer Center at Rocco and Nancy Ortenzio Cancer Pavilion (Radiation Oncology) patients have access to the most advanced radiation technology. We are focused on providing you with the most effective treatment while preserving your quality of life. Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "NRG Oncology" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion" are "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Prostate Adenocarcinoma" (3 trials), "Stage III Lung Cancer AJCC v8" (3 trials), "Stage IIIA Lung Cancer AJCC v8" (3 trials) and "Stage IIIC Lung Cancer AJCC v8" (3 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion" in a lesser frequency.

Most popular intervention types in "UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion" are "Drug" (23 trials), "Other" (18 trials), "Biological" (14 trials), "Radiation" (13 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Questionnaire Administration" (10 trials), "Computed Tomography" (9 trials), "Magnetic Resonance Imaging" (9 trials) and "Cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion" are 23 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion". undefined are not yet recruiting, 22 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".